California Public Employees Retirement System Vir Biotechnology, Inc. Transaction History

California Public Employees Retirement System

$141 Billion
Q3 2024

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 04, 2022	SELL	$21.19 - $40.01 $2.84 Million - $5.36 Million	-133,896 Closed	0 $0
Q4 2021 Feb 10, 2022	BUY	$30.97 - $54.03 $392,513 - $684,776	12,674 Added 10.46%	133,896 $5.61 Million
Q3 2021 Nov 10, 2021	SELL	$34.9 - $54.54 $395,556 - $618,156	-11,334 Reduced 8.55%	121,222 $5.28 Million
Q2 2021 Aug 13, 2021	SELL	$38.75 - $51.0 $363,320 - $478,176	-9,376 Reduced 6.61%	132,556 $6.27 Million
Q1 2021 May 14, 2021	BUY	$26.34 - $83.07 $606,952 - $1.91 Million	23,043 Added 19.38%	141,932 $7.28 Million
Q4 2020 Feb 02, 2021	SELL	$25.51 - $43.38 $58,673 - $99,774	-2,300 Reduced 1.9%	118,889 $3.18 Million
Q3 2020 Nov 05, 2020	BUY	$28.28 - $53.6 $777,388 - $1.47 Million	27,489 Added 29.34%	121,189 $4.16 Million
Q2 2020 Aug 12, 2020	BUY	$27.89 - $47.86 $2.61 Million - $4.48 Million	93,700 New	93,700 $3.84 Million

Others Institutions Holding VIR

# of Institutions

219

Shares Held

87.4M

Call Options Held

127K

Put Options Held

1.19M

Sb Investment Advisers (Uk) LTD London, X0

16.7M
Shares

$116 Million
1.03% of portfolio
Black Rock Inc. New York, NY

16.4M
Shares

$114 Million
0.0% of portfolio
Vanguard Group Inc Valley Forge, PA

13.1M
Shares

$91.3 Million
0.0% of portfolio
State Street Corp Boston, MA

5.63M
Shares

$39.1 Million
0.0% of portfolio
Orbimed Advisors LLC San Diego, CA

3.57M
Shares

$24.8 Million
0.63% of portfolio

View Full List

About Vir Biotechnology, Inc.

Ticker VIR
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 132,638,000
Market Cap $922M
Description
Vir Biotechnology, Inc., a commercial-stage immunology company, develops therapeutic products to treat and prevent serious infectious diseases. It develops Sotrovimab (VIR-7832), a SARS-CoV-2-neutralizing mAbs to treat and prevent COVID-19 infection under the Xevudy brand; VIR-2218 and VIR-3434 for the treatment of hepatitis B virus; VIR-2482 fo...

More about VIR

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of California Public Employees Retirement System, based on Form 13F filings with the SEC.

News

Stay updated on California Public Employees Retirement System with notifications on news.

Account